Imunon Inc (IMNN)
1.33
+0.02
(+1.53%)
USD |
NASDAQ |
May 03, 16:00
1.35
+0.02
(+1.50%)
After-Hours: 20:00
Imunon Free Cash Flow: -19.47M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.47M |
| September 30, 2023 | -20.75M |
| June 30, 2023 | -20.74M |
| March 31, 2023 | -19.48M |
| December 31, 2022 | -23.36M |
| September 30, 2022 | -23.43M |
| June 30, 2022 | -22.57M |
| March 31, 2022 | -19.70M |
| December 31, 2021 | -16.54M |
| September 30, 2021 | -15.16M |
| June 30, 2021 | -15.28M |
| March 31, 2021 | -15.52M |
| December 31, 2020 | -15.64M |
| September 30, 2020 | -17.53M |
| June 30, 2020 | -18.12M |
| March 31, 2020 | -19.91M |
| December 31, 2019 | -20.61M |
| September 30, 2019 | -8.949M |
| June 30, 2019 | -8.665M |
| March 31, 2019 | -8.176M |
| December 31, 2018 | -7.180M |
| September 30, 2018 | -17.44M |
| June 30, 2018 | -18.27M |
| March 31, 2018 | -18.21M |
| December 31, 2017 | -16.68M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.13M |
| June 30, 2017 | -16.75M |
| March 31, 2017 | -16.83M |
| December 31, 2016 | -18.44M |
| September 30, 2016 | -17.67M |
| June 30, 2016 | -18.31M |
| March 31, 2016 | -19.73M |
| December 31, 2015 | -20.94M |
| September 30, 2015 | -23.82M |
| June 30, 2015 | -24.56M |
| March 31, 2015 | -23.18M |
| December 31, 2014 | -22.03M |
| September 30, 2014 | -18.71M |
| June 30, 2014 | -15.25M |
| March 31, 2014 | -16.20M |
| December 31, 2013 | -9.583M |
| September 30, 2013 | -12.33M |
| June 30, 2013 | -14.93M |
| March 31, 2013 | -15.06M |
| December 31, 2012 | -22.76M |
| September 30, 2012 | -21.23M |
| June 30, 2012 | -23.02M |
| March 31, 2012 | -24.85M |
| December 31, 2011 | -23.32M |
| September 30, 2011 | -21.41M |
Free Cash Flow Range, Past 5 Years
-23.43M
Minimum
Sep 2022
-8.665M
Maximum
Jun 2019
-17.97M
Average
-19.47M
Median
Dec 2023
Free Cash Flow Benchmarks
| Avalo Therapeutics Inc | -30.68M |
| iBio Inc | -18.89M |
| Ocugen Inc | -72.53M |
| Petros Pharmaceuticals Inc | -7.626M |
| Moderna Inc | -3.672B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.772M |
| Cash from Investing (Quarterly) | -3.304M |
| Cash from Financing (Quarterly) | 0.0302M |
| Free Cash Flow Per Share (Quarterly) | -0.4012 |
| Free Cash Flow Yield | -161.8% |